![Michael Didocha](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Michael Didocha
Corporate Officer/Principal bij
TELIX PHARMACEUTICALS LIMITED
Profiel
Michael Didocha is currently the Chief Financial Officer-American Region at Telix Pharmaceuticals Ltd. He previously worked as a Finance Director at Roche Holding AG.
Mr. Didocha completed his undergraduate degree at Georgia Institute of Technology and holds an MBA from Kelley School of Business.
Actieve functies van Michael Didocha
| Bedrijven | Functie | Begin |
|---|---|---|
| TELIX PHARMACEUTICALS LIMITED | Corporate Officer/Principal | 31-08-2021 |
Eerdere bekende functies van Michael Didocha
| Bedrijven | Functie | Einde |
|---|---|---|
| ROCHE HOLDING AG | Financieel Directeur/CFO | - |
Opleiding van Michael Didocha
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
6
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
Roche Holding AG
 Roche Holding AG Pharmaceuticals: MajorHealth Technology Operates as a research-focused healthcare company with combined focus in pharmaceuticals and diagnostics | Health Technology |
Georgia Institute of Technology
 Georgia Institute of Technology Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Kelley School of Business
 Kelley School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Telix Pharmaceuticals Ltd.
 Telix Pharmaceuticals Ltd. BiotechnologyHealth Technology Operates as a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals | Health Technology |
